Join
Live feed
·
PRReleasevia Quantisnow
Metsera Inc. logo

Metsera Announces Positive Phase 1 Data of First-in-Class Once-Monthly Amylin Candidate MET-233i

ByQuantisnow·Wall Street's wire, on your screen.
MTSR· Metsera Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MTSR (Metsera Inc.) and more on Quantisnow.